These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30389408)

  • 1. Triazole-linked transition state analogs as selective inhibitors against V. cholerae sialidase.
    Slack TJ; Li W; Shi D; McArthur JB; Zhao G; Li Y; Xiao A; Khedri Z; Yu H; Liu Y; Chen X
    Bioorg Med Chem; 2018 Nov; 26(21):5751-5757. PubMed ID: 30389408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
    Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
    Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of delta4-beta-D-glucopyranosiduronic acids as mimetics of 2,3-unsaturated sialic acids for sialidase inhibition.
    Florio P; Thomson RJ; Alafaci A; Abo S; von Itzstein M
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2065-8. PubMed ID: 10450982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pneumoniae NanC: STRUCTURAL INSIGHTS INTO THE SPECIFICITY AND MECHANISM OF A SIALIDASE THAT PRODUCES A SIALIDASE INHIBITOR.
    Owen CD; Lukacik P; Potter JA; Sleator O; Taylor GL; Walsh MA
    J Biol Chem; 2015 Nov; 290(46):27736-48. PubMed ID: 26370075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 9-Azido-9-deoxy-2,3-difluorosialic Acid as a Subnanomolar Inhibitor against Bacterial Sialidases.
    Li W; Santra A; Yu H; Slack TJ; Muthana MM; Shi D; Liu Y; Chen X
    J Org Chem; 2019 Jun; 84(11):6697-6708. PubMed ID: 31083938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase.
    Haselhorst T; Wilson JC; Thomson RJ; McAtamney S; Menting JG; Coppel RL; von Itzstein M
    Proteins; 2004 Aug; 56(2):346-53. PubMed ID: 15211517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies.
    Li Y; Cao H; Yu H; Chen Y; Lau K; Qu J; Thon V; Sugiarto G; Chen X
    Mol Biosyst; 2011 Apr; 7(4):1060-72. PubMed ID: 21206954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,3-Didehydro-2-deoxysialic acids structurally varied at C-5 and their behaviour towards the sialidase from Vibrio cholerae.
    Schreiner E; Zbiral E; Kleineidam RG; Schauer R
    Carbohydr Res; 1991 Sep; 216():61-6. PubMed ID: 1797392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy for neuraminidase inhibitors using mechanism-based labeling information.
    Hinou H; Miyoshi R; Takasu Y; Kai H; Kurogochi M; Arioka S; Gao XD; Miura N; Fujitani N; Omoto S; Yoshinaga T; Fujiwara T; Noshi T; Togame H; Takemoto H; Nishimura S
    Chem Asian J; 2011 Apr; 6(4):1048-56. PubMed ID: 21305698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivalency and the mode of action of bacterial sialidases.
    Thobhani S; Ember B; Siriwardena A; Boons GJ
    J Am Chem Soc; 2003 Jun; 125(24):7154-5. PubMed ID: 12797770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation as sialidase inhibitors of xylo-configured cyclohexenephosphonates carrying glycerol side-chain mimics.
    Streicher H
    Bioorg Med Chem Lett; 2004 Jan; 14(2):361-4. PubMed ID: 14698159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high resolution structures of free and inhibitor-bound Trypanosoma rangeli sialidase and its comparison with T. cruzi trans-sialidase.
    Amaya MF; Buschiazzo A; Nguyen T; Alzari PM
    J Mol Biol; 2003 Jan; 325(4):773-84. PubMed ID: 12507479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unique sialidase that cleaves the Neu5Gcalpha2-->5-O(glycolyl)Neu5Gc linkage: comparison of its specificity with that of three microbial sialidases toward four sialic acid dimers.
    Inoue S; Lin SL; Inoue Y; Groves DR; Thomson RJ; von Itzstein M; Pavlova NV; Li SC; Li YT
    Biochem Biophys Res Commun; 2001 Jan; 280(1):104-9. PubMed ID: 11162485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the human cytosolic sialidase Neu2. Evidence for the dynamic nature of substrate recognition.
    Chavas LM; Tringali C; Fusi P; Venerando B; Tettamanti G; Kato R; Monti E; Wakatsuki S
    J Biol Chem; 2005 Jan; 280(1):469-75. PubMed ID: 15501818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility.
    Rudrawar S; Kerry PS; Rameix-Welti MA; Maggioni A; Dyason JC; Rose FJ; van der Werf S; Thomson RJ; Naffakh N; Russell RJ; von Itzstein M
    Org Biomol Chem; 2012 Nov; 10(43):8628-39. PubMed ID: 22976385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialidase Inhibitors with Different Mechanisms.
    Keil JM; Rafn GR; Turan IM; Aljohani MA; Sahebjam-Atabaki R; Sun XL
    J Med Chem; 2022 Oct; 65(20):13574-13593. PubMed ID: 36252951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
    Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
    Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C-4 position.
    Holzer CT; von Itzstein M; Jin B; Pegg MS; Stewart WP; Wu WY
    Glycoconj J; 1993 Feb; 10(1):40-4. PubMed ID: 8358225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.
    Hyun SW; Liu A; Liu Z; Cross AS; Verceles AC; Magesh S; Kommagalla Y; Kona C; Ando H; Luzina IG; Atamas SP; Piepenbrink KH; Sundberg EJ; Guang W; Ishida H; Lillehoj EP; Goldblum SE
    Glycobiology; 2016 Aug; 26(8):834-49. PubMed ID: 27226251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.
    Kai H; Hinou H; Nishimura S
    Bioorg Med Chem; 2012 Apr; 20(8):2739-46. PubMed ID: 22410247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.